Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brulant was a prominent digital strategy and technology consulting firm that specialized in interactive marketing, e-commerce, and enterprise technology solutions. While not a biotechnology or pharmaceutical developer, the company maintained a significant Healthcare and Life Sciences practice, providing digital transformation services for major healthcare systems and pharmaceutical clients. The firm was recognized for its expertise in building complex digital platforms and implementing agile development methodologies. In 2008, Brulant was acquired by Rosetta for approximately $100 million, and it was subsequently integrated into the Publicis Groupe following Publicis' acquisition of Rosetta in 2011.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brulant.